#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA656823	F	Cytotoxicity measured using the COR-L23 parental (COR-L23/P) human non small cell lung carcinoma cell line	Homo sapiens	10	ALA1135980	cell-based format	Scientific Literature
2.	ALA656824	F	Cytotoxicity measured with the drug resistant human non small cell lung carcinoma cell line COR-L23 (COR-L23/R) which over expresses multidrug resistance associated with protein(MRP)	Homo sapiens	10	ALA1135980	cell-based format	Scientific Literature
3.	ALA656830	F	Cytotoxicity against lung carcinoma COR-L23/CTR tumor cell lines	Homo sapiens	2	ALA1148403	cell-based format	Scientific Literature
4.	ALA873540	F	In vitro inhibitory concentration against human carcinoma COR-L23 cells in the presence of vinblastine sulfate salt	Homo sapiens	9	ALA1143463	cell-based format	Scientific Literature
5.	ALA984407	F	Cytotoxicity against human COR-L23 cells assessed as fraction of viable cells after 72 hrs relative to control	Homo sapiens	13	ALA1149823	cell-based format	Scientific Literature
6.	ALA993364	F	Antiproliferative activity against human COR-L23 cells after 48 hrs by sulforhodamine B assay	Homo sapiens	8	ALA1142461	cell-based format	Scientific Literature
7.	ALA1060501	F	Cytotoxicity against human COR-L23 cells after 48 hrs by SRB assay	Homo sapiens	6	ALA1152950	cell-based format	Scientific Literature
8.	ALA1768942	F	Growth inhibition in human COR-L23 cells at 0.2 uM by SRB assay	Homo sapiens	12	ALA1764979	cell-based format	Scientific Literature
9.	ALA1768943	F	Potentiation of pemetrexed-induced growth inhibitory activity in human COR-L23 cells at 1 uM by SRB assay in presence of thymidine and hypoxanthine	Homo sapiens	12	ALA1764979	cell-based format	Scientific Literature
10.	ALA1805218	F	Antiproliferative activity against human COR-L23 cells after 72 hrs by WST-1 assay	Homo sapiens	3	ALA1800056	cell-based format	Scientific Literature
11.	ALA1805219	F	Antiproliferative activity against doxorubicin-resistant human COR-L23 cells after 72 hrs by WST-1 assay	Homo sapiens	3	ALA1800056	cell-based format	Scientific Literature
12.	ALA1805233	F	Ratio of GI50 for SAHA to compound for human COR-L23 cells after 72 hrs by WST-1 assay	Homo sapiens	1	ALA1800056	cell-based format	Scientific Literature
13.	ALA1805234	F	Ratio of GI50 for SAHA to compound for doxorubicin-resistant human COR-L23 cells after 72 hrs by WST-1 assay	Homo sapiens	1	ALA1800056	cell-based format	Scientific Literature
14.	ALA2363144	F	SANGER: Inhibition of human COR-L23 cell growth in a cell viability assay.	Homo sapiens	98	ALA1201861	cell-based format	Sanger Institute Genomics of Drug Sensitivity in Cancer
15.	ALA4184877	F	Antiproliferative activity against human COR-L23 cells after 4 days by CellTiter-Glo assay	Homo sapiens	28	ALA4184107	cell-based format	Scientific Literature
16.	ALA4184879	F	Antitumor activity against human COR-L23 cells xenografted in nude mouse assessed as reduction in tumor growth at 10 mg/kg, po bid administered for 3 days starting from day 7 post implantation measured every 2 to 3 days for 18 days	Homo sapiens	1	ALA4184107	organism-based format	Scientific Literature
17.	ALA4184880	F	Antitumor activity against human COR-L23 cells xenografted in nude mouse assessed as reduction in tumor growth at 15 to 30 mg/kg, po bid administered for 6 days starting from day 7 post implantation measured every 2 to 3 days for 18 days	Homo sapiens	1	ALA4184107	organism-based format	Scientific Literature
18.	ALA4410834	F	Antiproliferative activity against human COR-L23 cells incubated for 72 hrs by CellTiterGlo assay	Homo sapiens	28	ALA4406910	cell-based format	Scientific Literature